Title : A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.

Pub. Date : 2016 Sep

PMID : 26764527






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin heat shock protein 90 alpha family class A member 1 Homo sapiens
2 A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin heat shock protein 90 alpha family class A member 1 Homo sapiens